{"transactions":[{"id":829639,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T18:30:41.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying the restricted stock unit award shall vest as to 1/16th of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying the restricted stock unit award shall vest as to 1/16th of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company."}],"balance_after":3087,"derivative":{"underlying":"Common Stock","underlying_shares":221},"source":{"system":"sec-edgar","filing":"0001193125-26-122341","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312526122341/ownership.xml","form_type":"4"}},{"id":829638,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T18:30:41.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the restricted stock unit award shall vest as to 25% of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the restricted stock unit award shall vest as to 25% of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company."}],"balance_after":12119,"derivative":{"underlying":"Common Stock","underlying_shares":865},"source":{"system":"sec-edgar","filing":"0001193125-26-122341","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312526122341/ownership.xml","form_type":"4"}},{"id":829637,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Common Stock","published_at":"2026-03-24T18:30:41.000Z","date":"2026-03-20","kind":"sale","planned":false,"acquired":false,"shares":80,"price":8.61,"value":688.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction represents an automatic sale to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":47055,"source":{"system":"sec-edgar","filing":"0001193125-26-122341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312526122341/ownership.xml","form_type":"4"}},{"id":829636,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Common Stock","published_at":"2026-03-24T18:30:41.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":221,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":47135,"source":{"system":"sec-edgar","filing":"0001193125-26-122341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312526122341/ownership.xml","form_type":"4"}},{"id":829635,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Common Stock","published_at":"2026-03-24T18:30:41.000Z","date":"2026-03-20","kind":"sale","planned":false,"acquired":false,"shares":310,"price":8.61,"value":2669.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction represents an automatic sale to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":46914,"source":{"system":"sec-edgar","filing":"0001193125-26-122341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312526122341/ownership.xml","form_type":"4"}},{"id":829634,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Common Stock","published_at":"2026-03-24T18:30:41.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":865,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":47224,"source":{"system":"sec-edgar","filing":"0001193125-26-122341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312526122341/ownership.xml","form_type":"4"}},{"id":959934,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Restricted Stock Units","published_at":"2025-12-23T21:05:45.000Z","date":"2025-12-20","kind":"exercise","planned":false,"acquired":false,"shares":220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying the restricted stock unit award shall vest as to 1/16th of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying the restricted stock unit award shall vest as to 1/16th of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company."}],"balance_after":3308,"derivative":{"underlying":"Common Stock","underlying_shares":220},"source":{"system":"sec-edgar","filing":"0001193125-25-331299","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312525331299/ownership.xml","form_type":"4"}},{"id":959933,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Restricted Stock Units","published_at":"2025-12-23T21:05:45.000Z","date":"2025-12-20","kind":"exercise","planned":false,"acquired":false,"shares":866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the restricted stock unit award shall vest as to 25% of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the restricted stock unit award shall vest as to 25% of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company."}],"balance_after":12984,"derivative":{"underlying":"Common Stock","underlying_shares":866},"source":{"system":"sec-edgar","filing":"0001193125-25-331299","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312525331299/ownership.xml","form_type":"4"}},{"id":959932,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Common Stock","published_at":"2025-12-23T21:05:45.000Z","date":"2025-12-20","kind":"sale","planned":false,"acquired":false,"shares":79,"price":8.68,"value":685.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction represents an automatic sale to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":46359,"source":{"system":"sec-edgar","filing":"0001193125-25-331299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312525331299/ownership.xml","form_type":"4"}},{"id":959931,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Common Stock","published_at":"2025-12-23T21:05:45.000Z","date":"2025-12-20","kind":"exercise","planned":false,"acquired":true,"shares":220,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":46438,"source":{"system":"sec-edgar","filing":"0001193125-25-331299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312525331299/ownership.xml","form_type":"4"}},{"id":959930,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Common Stock","published_at":"2025-12-23T21:05:45.000Z","date":"2025-12-20","kind":"sale","planned":false,"acquired":false,"shares":310,"price":8.68,"value":2690.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction represents an automatic sale to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":46218,"source":{"system":"sec-edgar","filing":"0001193125-25-331299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312525331299/ownership.xml","form_type":"4"}},{"id":959929,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":56340,"kind":"person","name":"Gupta Ashoo","position":1,"cik":"0002091461","reported_name":"Gupta Ashoo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Controller"}}],"security":"Common Stock","published_at":"2025-12-23T21:05:45.000Z","date":"2025-12-20","kind":"exercise","planned":false,"acquired":true,"shares":866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":46528,"source":{"system":"sec-edgar","filing":"0001193125-25-331299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2091461/000119312525331299/ownership.xml","form_type":"4"}}]}